Nocturnal oxygen therapy as an option for early COVID-19

Chongxing Shen; Xiaofeng Yue; Jianwu Wang; Chunmeng Shi; Weibing Li

doi:10.1016/j.ijid.2020.06.080

Nocturnal oxygen therapy as an option for early COVID-19

Int J Infect Dis. 2020 Sep:98:176-179. doi: 10.1016/j.ijid.2020.06.080. Epub 2020 Jun 26.

Authors

Chongxing Shen¹, Xiaofeng Yue¹, Jianwu Wang¹, Chunmeng Shi², Weibing Li³

Affiliations

¹ Department of Urology, The Third Affiliated Hospital (General Hospital) of Chongqing Medical University, Chongqing, China.
² Institute of Rocket Force Medicine, State Key Laboratory of Trauma, Burns and Combined Injury, Third Military Medical University, Chongqing, China. Electronic address: shicm@tmmu.edu.cn.
³ Department of Urology, The Third Affiliated Hospital (General Hospital) of Chongqing Medical University, Chongqing, China. Electronic address: liweibing63@cqmu.edu.cn.

Abstract

There is currently no effective antiviral therapy or immune-based treatment for coronavirus disease (COVID-19). The urgent challenge is to prevent the transition of COVID-19 from mild to severe infection. This paper discussed nocturnal oxygen therapy as a new option for people with COVID-19 under home quarantine. It suggested that nocturnal oxygen therapy in the early stages may be helpful in preventing disease progression by inhibiting the rapid replication of the virus and improving the body's antiviral ability.

Keywords: COVID-19; Coronavirus; Immunomodulation; Nocturnal oxygen therapy; SARS-CoV-2.

MeSH terms

Betacoronavirus*
COVID-19
Coronavirus Infections / complications
Coronavirus Infections / therapy*
Humans
Hypoxia / etiology
Hypoxia / therapy
Oxygen / therapeutic use*
Pandemics
Pneumonia, Viral / complications
Pneumonia, Viral / therapy*
SARS-CoV-2

Substances

Oxygen